Individualized prostate biopsy strategy for Chinese patients with different prostate-specific antigen levels

Asian Journal of Andrology

Volumn 10, Issue 2, 2008, Pages 325-331

  Dai, Bo ^a   Ye, Ding Wei ^a   Kong, Yun Yi ^a   Shen, Yi Jin ^a   Wang, Bo Hua ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Asian continental ancestry group; Biopsy; Diagnosis; Prostate; Prostatic neoplasms

Indexed keywords

ANTIANDROGEN; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BIOPSY TECHNIQUE; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CHINESE; CLINICAL PROTOCOL; CONTROLLED STUDY; DIAGNOSTIC VALUE; DIGITAL RECTAL EXAMINATION; GLEASON SCORE; HISTOPATHOLOGY; HORMONAL THERAPY; HUMAN; INDIVIDUALIZATION; LIFE EXPECTANCY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PATIENT SELECTION; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; TRANSRECTAL ULTRASONOGRAPHY;

AGED; AGED, 80 AND OVER; BIOPSY, NEEDLE; CHINA; HUMANS; MALE; MIDDLE AGED; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS;

EID: 40349085363     PISSN: 1008682X     EISSN: 17457262     Source Type: Journal    
DOI: 10.1111/j.1745-7262.2008.00345.x     Document Type: Article

References (20)

1. Parkin DM. Global cancer statistics in the year 2000. Lancet Oncol 2001 2: 533-43.
2. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, et al. Cancer statistics, 2006. CA Cancer J Clin 2006 56: 106-30.
3. Ye DW. The epidemiological study of prostate cancer in China past, present and future. Chin J Surg 2006 44: 362-4.
4. Hodge KK, McNeal JE, Terris MK, Stamey TA. Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol 1989 142: 71-4.
5. Eichler K, Hempel S, Wilby J, Myers L, Bachmann LM, Kleijnen J. Diagn ostic value of systematic biopsy methods in the investigation of prostate cancer: A systematic review. J Urol 2006 175: 1605-12.
6. Terris MK, Stamey TA. Determination of prostate volume by transrectal ultrasound. J Urol 1991 145: 984-7.
7. Ravery V, Goldblatt L, Royer B, Blanc E, Toublanc M, Boccon-Gibod L. Extensive biopsy protocol improves the detection rate of prostate cancer. J Urol 2000 164: 393-6.
8. Eskicorapci S Y, Baydar DE, Akbal C, Sofikerim M, Günay M, Ekici S, et al. An extended 10-core transrectal ultrasonography guided prostate biopsy protocol improves the detection of prostate cancer. Eur Urol 2004 45: 444-9.
9. Djavan B, Margreiter M. Biopsy standards for detection of prostate cancer. World J Urol 2007 25: 11-7.
10. Al-Ghazo MA, Ghalayini IF, Matalka II. Ultrasound-guided transrectal extended prostate biopsy: A prospective study. Asian J Androl 2005 7: 165-9.
11. Freedland SJ, Partin AW. Prostate-specific antigen: Update 2006. Urology 2006 67: 458-60.
12. Gao HW, Li YL, Wu S, Wang YS, Zhang HF, Pan YZ, et al. Mass screening of prostate cancer in a Chinese population: The relationship between pathological features of prostate cancer and serum prostate specific antigen. Asian J Androl 2005 7: 159-63.
13. Peyromaure M, Debré B, Mao K, Zhang G, Wang Y, Sun Z, et al. Management of prostate cancer in China: A multicenter report of 6 institutions. J Urol 2005 174: 1794-7.
14. Montironi R, Vela Navarrete R, Lopez-Beltran A, Mazzucchelli R, Mikuz G, Bono AV. Histopathology reporting of prostate needle biopsies. 2005 update. Virchows Arch 2006 449: 1-13.
15. Elabbady AA, Khedr MM. Extended 12-core prostate biopsy increases both the detection of prostate cancer and the accuracy of Gleason score. Eur Urol 2006 49: 49-53.
16. Naya Y, Ochiai A, Troncoso P, Babaian RJ. A comparison of extended biopsy and sextant biopsy schemes for predicting the pathological stage of prostate cancer. J Urol 2004 171: 2203-8.
17. Ochiai A, Troncoso P, Chen ME, Lloreta J, Babaian RJ. The relationship between tumor volume and the number of positive cores in men undergoing multisite extended biopsy: Implication for expectant management. J Urol 2005 174: 2164-8.
18. Peyromaure M, Ravery V, Messas A, Toublanc M, Boccon-Gibod L, Boccon-Gibod L. Pain and morbidity of an extensive prostate 10-biopsy protocol: A prospective study in 289 patients. J Urol 2002 167: 218-21.
19. Naughton CK, Ornstein DK, Smith DS, Catalona WJ. Pain and morbidity of transrectal ultrasound guided prostate biopsy: A prospective randomized trial of 6 versus 12 cores. J Urol 2000 163: 168-71.
20. Paul R, Schöler S, van Randenborgh H, Kübler H, Alschibaja M, Busch R, et al. Morbidity of prostatic biopsy for different biopsy strategies: Is there a relation to core number and sampling region? Eur Urol 2004 45: 450-5.